Slow release anti tuberculous drugs as a treatment of choice in anticipating failure in extra pulmonaryTB medication

Published by Admin Journal on

Issue
Apr
Year
Volume
1
No. 1

Abstract

Introduction

Tuberculous infection remain major health problem in the world. Indonesia is the third TB contributor after china and India. Around 65% TB infection is extra pulmonaryTB including musculoskeletal TB.

MusculoskeletalTBis an infection in the bone and surrounding soft tissue by Mycobacterium tuberculosis and result in tissue destruction. To date, we depends mainly on oral antuberculous drugs ie. Rifampicin, INH, pyrazinamide, streptomycin and ethambutol. The same regiment is also used in extra pulmonaryTB including spondylitis TB.

Materials and methods

Results

Conclusion

Download File

Categories: